Delivery Order SPE2DB20D3103-SPE2DB24FN0Q5
- Not listed
- This federal contract award is for the delivery of 4,564,361,766 units of NovoLog 100 Unit/mL Flexpen 3mL, a prescription medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, with a ceiling value of $3,025.76. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,225.44 firm fixed price delivery order to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $2,413.04 to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has a completion date of February 6, 2024 and was awarded on February 5, 2024. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, through which the...
- This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies to the Defense Logistics Agency (DLA). The $2,490.60 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,073.54 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 12, 2024, with a completion date of December 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $4,002.84 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 19, 2025. The contract is not designated with a...
- This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,262.17 firm-fixed-price delivery order has an ultimate completion date of April 26, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical products to the Defense Logistics Agency (DLA). The contract, valued at $1,738.17, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 19, 2024. The contract is not associated with a set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,790.81 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4564589907 NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a period of performance through May 14, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which...
- This federal contract award is for the delivery of Novolog 100 unit/mL Flexpen 3mL to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,084.80 and is a firm fixed-price delivery order that runs through March 23, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN0Q5Delivery Order
This federal contract award is for the delivery of NovoLog 100 unit/mL FlexPen 3mL, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,275.80, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 15, 2024. This is a delivery order contract with a firm fixed price, and the ultimate completion date is March 18, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award is not designated as a set-aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 3/15/24 |